TCL Archive Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years September 28, 2012
TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive In Brief: Louisville Cancer Center Developed With No Federal, State Money Or Fund Raising Costs May 30, 1980